Ionis headquarters
Pharma

FDA approves transformational expansion of Ionis’ Tryngolza

Ionis has gained a transformational FDA expansion for Tryngolza to become the first treatment to reduce the risk of acute pancreatitis that accompanies severe hypertriglyceridemia.
Kevin Dunleavy Jun 25, 2026 8:13am
Beyond China and Japan How biopharma is expanding rare disease access across Asia-Pacific

Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific

Brought to you by DKSH
Supreme Court building in Washington DC

SCOTUS ruling blunts state-level claims against Bayer's Roundup

Jun 25, 2026 1:52pm
The legacy approach to real-world data is costing you

The legacy approach to real-world data is costing you

Brought to you by HealthVerity
FDA

FDA finds fault with Pinnacle’s photodynamic therapy videos

Jun 25, 2026 10:12am
Four large while puzzle pieces are being connected together on a dark brown table by four sets of hands

Merck KGaA charts biggest deal in 10+ years with Bio-Techne buy

Jun 25, 2026 9:56am
More News

AstraZeneca spells out a cancer screening strategy with the YMCA

Jun 25, 2026 4:30am

Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC

Jun 24, 2026 5:00pm
Fierce Biotech

Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO

Jun 24, 2026 3:03pm

FDA approves breast cancer expansion for Pfizer's Ibrance

Jun 24, 2026 2:48pm